Vibhavadi Medical Center PCLBKK:VIBHA-R 71 3-Year EBITDA Growth Rate is 1.00% as of Mar. 2026, which is 93% below its 10-year median of 13.60. GuruFocus rates BKK:VIBHA-R with a GF Score™ of 71/100 and a GF Value™ of ฿1.60. The stock has 5 warning signs investors should review. Among 529 Healthcare Providers & Services companies, Vibhavadi Medical Center PCL ranks worse than 68.43% on this metric.
During the past 12 months, Vibhavadi Medical Center PCL's average EBITDA Per Share Growth Rate was 154.80% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 1.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 7.50% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 4.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Vibhavadi Medical Center PCL was 39.20% per year. The lowest was -15.80% per year. And the median was 13.60% per year.
Vibhavadi Medical Center PCL (BKK:VIBHA-R) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Vibhavadi Medical Center PCL 3-Year EBITDA Growth Rate Related Terms
BKK:VIBHA-R vs HCA, THC, DVA: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibhavadi Medical Center PCL 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Vibhavadi Medical Center PCL's 3-Year EBITDA Growth Rate falls into.
Vibhavadi Medical Center PCL 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 1.00% mean?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a 3-Year EBITDA Growth Rate of 1.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Vibhavadi Medical Center PCL and its competitors. This is 93% below median its historical median of 13.60. According to the industry distribution chart, Vibhavadi Medical Center PCL ranks #362 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 68.4%.
Is Vibhavadi Medical Center PCL's 3-Year EBITDA Growth Rate too high?
Vibhavadi Medical Center PCL's current 3-Year EBITDA Growth Rate of 1.00% is 93% below median its 10-year median of 13.60. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 9.90. Vibhavadi Medical Center PCL's value of 1.00% is 89.9% below this industry median. Based on the distribution chart, Vibhavadi Medical Center PCL ranks #362 out of 529 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Vibhavadi Medical Center PCL ranks #362 out of 529 companies for 3-Year EBITDA Growth Rate. This places Vibhavadi Medical Center PCL in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 9.90. Vibhavadi Medical Center PCL's value of 1.00% is 89.9% below this benchmark. While the company's 10-year median is 13.60 vs. the industry median of 9.90, Vibhavadi Medical Center PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.90, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibhavadi Medical Center PCL's current 3-Year EBITDA Growth Rate of 1.00% is 89.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Vibhavadi Medical Center PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibhavadi Medical Center PCL's current 3-Year EBITDA Growth Rate is 1.00%, which is 93% below median its own 10-year median of 13.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a current 3-Year EBITDA Growth Rate of 1.00%. The stock's GF Value™ is ฿1.60, compared to a current price of ฿1.36 — trading 15% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 1.00%, which is 93% below median its 10-year median of 13.60 and 89.9% below the Healthcare Providers & Services industry median of 9.90. Vibhavadi Medical Center PCL's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA-R), the current 3-Year EBITDA Growth Rate is 1.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibhavadi Medical Center PCL (BKK:VIBHA-R) Overvalued in 2026?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued.
The current stock price of ฿1.36 is trading 15% below its estimated GF Value™ of ฿1.60.
Key valuation signals for BKK:VIBHA-R:
3-Year EBITDA Growth Rate: 1.00% (93% below median its 10-year median of 13.60)
GF Value™: ฿1.60 vs. price of ฿1.36 (15% below fair value)
Industry Position: 89.9% below the Healthcare Providers & Services median (#362 of 529)
No single metric tells the full story. See the BKK:VIBHA-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
71GF Score
Get the complete analysis for BKK:VIBHA-R
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIBHA-R has been successfully added to your 